gabexate has been researched along with Fetal Growth Restriction in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murata, M | 1 |
| Hayakawa, M | 1 |
| Goto, K | 1 |
| Isobe, K | 1 |
| Matuura, T | 1 |
| Hirano, H | 1 |
| Higuchi, M | 1 |
| Maki, M | 1 |
1 other study available for gabexate and Fetal Growth Restriction
| Article | Year |
|---|---|
[Anticoagulant therapy in obstetrical disorders].
Topics: Antithrombin III; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Fetal G | 1990 |